SCR-LIP-000301 · Claim · machine-readable JSON →
In 360 Italian women with lipedema (a peripheral/gynoid fat distribution), inflammatory and metabolic markers worsened with disease stage: CRP rose from 1.38 to 4.93 mg/L (p<0.001, persisting after adjustment for age and BMI), HOMA-IR increased from 1.75 to 2.92, 34% had glucose metabolism alterations, HDL fell and obesity prevalence climbed from 6.3% to 91.8% across stages.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Observational Study on a Large Italian Population with Lipedema: Biochemical and Hormonal Profile, Anatomical and Clinical Evaluation, Self-Reported History — Patton et al. (2024) ✓ verified — conflicting · cross sectional · 2024 · reading confidence: high
“PCR aumenta com estágio: Estágio 1: 1,38±1,29 mg/L → Estágio 2: 1,94±1,69 mg/L → Estágio 3: 4,93±4,35 mg/L (p<0,001); diferença mantida após correção para idade e IMC”
Large observational study showing lipedema (peripheral fat) is associated with increasing inflammation, insulin resistance, and adverse lipid profile with stage, with CRP elevation persisting after adjustment for BMI — contradicting the not
Context (PECO)
Answers these questions
- Does a lipedema-like (peripheral/gynoid) fat distribution protect against cancer or metabolic disease? conflicting
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000010